CVS Group (CVSG) Stock Overview
Engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
CVSG Community Fair Values
Create NarrativeSee what 22 others think this stock is worth. Follow their fair value or set your own to get alerts.
CVS Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£11.32 |
| 52 Week High | UK£16.48 |
| 52 Week Low | UK£8.85 |
| Beta | 1.03 |
| 1 Month Change | -13.59% |
| 3 Month Change | -11.84% |
| 1 Year Change | 11.42% |
| 3 Year Change | -38.88% |
| 5 Year Change | -38.07% |
| Change since IPO | 395.40% |
Recent News & Updates
Recent updates
CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
Jan 10
At UK£12.08, Is CVS Group plc (LON:CVSG) Worth Looking At Closely?
Nov 10Investors Appear Satisfied With CVS Group plc's (LON:CVSG) Prospects
Oct 24Is There An Opportunity With CVS Group plc's (LON:CVSG) 30% Undervaluation?
Oct 08CVS Group plc's (LON:CVSG) P/E Is Still On The Mark Following 25% Share Price Bounce
May 23CVS Group plc (LON:CVSG) Shares Could Be 44% Below Their Intrinsic Value Estimate
Mar 14
Australian Veterinary Expansion And Investments Will Create Future Opportunities
CVS Group's strategic expansions and acquisitions in Australia could drive future revenue growth and increased market share.Market Participants Recognise CVS Group plc's (LON:CVSG) Earnings Pushing Shares 26% Higher
Jan 30CVS Group (LON:CVSG) Has A Somewhat Strained Balance Sheet
Dec 04CVS Group plc's (LON:CVSG) Price In Tune With Earnings
Oct 16Should You Think About Buying CVS Group plc (LON:CVSG) Now?
Sep 10CVS Group (LON:CVSG) Is Doing The Right Things To Multiply Its Share Price
Jun 05CVS Group (LON:CVSG) Has A Pretty Healthy Balance Sheet
Mar 28CVS Group (LON:CVSG) Is Looking To Continue Growing Its Returns On Capital
Feb 29Getting In Cheap On CVS Group plc (LON:CVSG) Is Unlikely
Feb 09Is It Too Late To Consider Buying CVS Group plc (LON:CVSG)?
Dec 11Most Shareholders Will Probably Agree With CVS Group plc's (LON:CVSG) CEO Compensation
Nov 23Is CVS Group (LON:CVSG) A Risky Investment?
Nov 15CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 89% Above Its Share Price
Oct 27Here's Why CVS Group (LON:CVSG) Has Caught The Eye Of Investors
Sep 23CVS Group's (LON:CVSG) Returns On Capital Are Heading Higher
Sep 08We Think CVS Group (LON:CVSG) Can Stay On Top Of Its Debt
Jun 28Should You Investigate CVS Group plc (LON:CVSG) At UK£20.72?
May 25A Look At The Fair Value Of CVS Group plc (LON:CVSG)
May 12Should You Be Adding CVS Group (LON:CVSG) To Your Watchlist Today?
Apr 15A Look At The Fair Value Of CVS Group plc (LON:CVSG)
Feb 01Here's Why We Think CVS Group (LON:CVSG) Might Deserve Your Attention Today
Jan 05Returns At CVS Group (LON:CVSG) Are On The Way Up
Nov 30CVS Group plc's (LON:CVSG) CEO Looks Like They Deserve Their Pay Packet
Nov 17CVS Group plc's (LON:CVSG) Intrinsic Value Is Potentially 41% Above Its Share Price
Oct 26Shareholder Returns
| CVSG | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -2.1% | -1.0% | 2.4% |
| 1Y | 11.4% | -0.9% | 20.5% |
Return vs Industry: CVSG exceeded the UK Healthcare industry which returned -2.4% over the past year.
Return vs Market: CVSG underperformed the UK Market which returned 17.9% over the past year.
Price Volatility
| CVSG volatility | |
|---|---|
| CVSG Average Weekly Movement | 3.2% |
| Healthcare Industry Average Movement | 6.6% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in GB Market | 11.4% |
| 10% least volatile stocks in GB Market | 3.1% |
Stable Share Price: CVSG has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: CVSG's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 9,000 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group plc Fundamentals Summary
| CVSG fundamental statistics | |
|---|---|
| Market cap | UK£794.17m |
| Earnings (TTM) | UK£16.50m |
| Revenue (TTM) | UK£692.80m |
Is CVSG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSG income statement (TTM) | |
|---|---|
| Revenue | UK£692.80m |
| Cost of Revenue | UK£393.20m |
| Gross Profit | UK£299.60m |
| Other Expenses | UK£283.10m |
| Earnings | UK£16.50m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Sep 24, 2026
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 43.24% |
| Net Profit Margin | 2.38% |
| Debt/Equity Ratio | 56.9% |
How did CVSG perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/01 05:42 |
| End of Day Share Price | 2026/04/01 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Group plc is covered by 13 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sharanya Gajapathy | Barclays |
| James Bayliss | Berenberg |
| Allan Smylie | Davy |